Next Article in Journal
Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18–49 Years of Age Enrolled at Center for Indigenous Health Sites
Previous Article in Journal
Oportuna Vacuna: A Prospective Study of Vaccine Confidence and Vaccine Uptake in a Low-Income, Spanish-Speaking Rhode Island Population in the Post-Pandemic Era
 
 
Article

Article Versions Notes

Action Date Notes Link
article html file updated 19 December 2025 12:59 CET Original file https://www.mdpi.com/2076-393X/14/1/4/html
article supplementary file uploaded. 19 December 2025 12:57 CET - https://www.mdpi.com/2076-393X/14/1/4#supplementary
article pdf uploaded. 19 December 2025 12:57 CET Version of Record https://www.mdpi.com/2076-393X/14/1/4/pdf
article xml uploaded. 19 December 2025 12:57 CET Update https://www.mdpi.com/2076-393X/14/1/4/xml
article xml file uploaded 19 December 2025 12:57 CET Original file -
Back to TopTop